X4 Pharmaceuticals Newsroom

B.Riley Financial Maintains X4 Pharmaceuticals(XFOR.US) With Hold Rating, Cuts Target Price to $0.5

Futu NewsNov 19 16:39

B. Riley Adjusts X4 Pharmaceuticals Price Target to $0.50 From $1, Maintains Neutral Rating

MT NewswiresNov 18 22:02

X4 Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 15 02:19

Stifel Maintains Buy on X4 Pharmaceuticals, Lowers Price Target to $4

BenzingaNov 14 17:53

X4 Pharmaceuticals (XFOR) Gets a Buy From Piper Sandler

TipRanksAug 9 20:57

Buy Rating Affirmed on X4 Pharmaceuticals: A Comprehensive Analysis of Financial Stability and Drug Development Progress

TipRanksAug 9 19:20

X4 Pharmaceuticals Analyst Ratings

BenzingaJun 28 19:40

HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $5 Price Target

BenzingaJun 28 19:40

X4 Pharmaceuticals Analyst Ratings

BenzingaMay 31 23:00

Cantor Fitzgerald Reiterates Overweight on X4 Pharmaceuticals, Maintains $5 Price Target

BenzingaMay 31 23:00

X4 Pharmaceuticals (XFOR) Gets a Buy From Piper Sandler

TipRanksMay 8 19:22

Optimistic Buy Rating for X4 Pharmaceuticals Following FDA Approval and Strong Clinical Prospects

TipRanksMay 8 18:32

X4 Pharmaceuticals Analyst Ratings

BenzingaApr 30 18:55

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

BenzingaApr 30 18:55

Buy Rating Affirmed for X4 Pharmaceuticals' Xolremdi on Robust Clinical Efficacy and Favorable Market Strategy

TipRanksApr 30 18:25

X4 Pharmaceuticals Analyst Ratings

BenzingaMar 23 02:55

HC Wainwright & Co. Reiterates Buy on X4 Pharmaceuticals, Maintains $3 Price Target

BenzingaMar 23 02:55

Buy Rating Affirmed on X4 Pharmaceuticals Amid Positive Mavorixafor Prospects

TipRanksMar 22 18:31

B. Riley Securities Downgrades X4 Pharmaceuticals to Neutral, Lowers Price Target to $1

BenzingaDec 12, 2023 21:12

X4 Pharmaceuticals Analyst Ratings

BenzingaDec 12, 2023 21:10